The Impact of Chronic E-Cigarette Usage on Microvascular Health
NCT ID: NCT06860698
Last Updated: 2026-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
44 participants
OBSERVATIONAL
2023-07-14
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigation of the Effects of Electronic Cigarettes on Vascular Health
NCT03041493
Sex Differences in the Vascular Effects of E-cigarette Use
NCT06159608
Acute Effects of E-Cigarette Aerosol Inhalation
NCT03479203
Does Switching to Nicotine Containing Electronic Cigarettes Reduce Health Risk Markers
NCT03625986
Vascular Effects of a Single Bout of Electronic Cigarette Use
NCT03209661
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chronic e-cigs users
Used e-cigarettes with nicotine (≥3 times/week for ≥6 months)
E-cig use
Based on e-cigarette usage, participants will be divided into those who used e-cigarettes and those who did not use e-cigarettes
Never Users
Use of cigarettes or other tobacco products less than 50 times in their lifetime.
E-cig use
Based on e-cigarette usage, participants will be divided into those who used e-cigarettes and those who did not use e-cigarettes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
E-cig use
Based on e-cigarette usage, participants will be divided into those who used e-cigarettes and those who did not use e-cigarettes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Used e-cigarettes with nicotine (≥3 times/week for ≥6 months)
Exclusion Criteria
* Former combustible tobacco user/ former smoker
* Use of cigarettes for 15 days or more in the past 60 days
* Use of other tobacco products (cigars, hookah, smokeless), marijuana and/or illicit or prescription drugs weekly or more frequently in the past 60 days
* Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, cerebral diseases or sleep disorders
* Disorder or use of medication that affects cardiopulmonary health
* Evidence of pregnancy or current nursing
Non e-Cig using arm
Inclusion
\- Between 18 and 29 years of age
Exclusion
* 17 years old and younger or 30 years old and older
* Use of cigarettes or other tobacco products more than 50 times in their lifetime.
* Evidence of cardiovascular, pulmonary, renal, hepatic, metabolic, cerebral diseases or sleep disorders
* Disorder or use of medication that affects cardiopulmonary health
* Evidence of pregnancy or current nursing
18 Years
29 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Virginia Commonwealth University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paula Rodriguez Miguelez
Role: PRINCIPAL_INVESTIGATOR
Virginia Commonwealth University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Virginia Commonwealth University
Richmond, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HM20029023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.